Sodium–Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 Diabetes

Diabetes and heart failure (HF) are closely linked, with one causing a worse prognosis in the other. The majority of anti-hyperglycaemic agents primarily reduce risk of ischaemic microvascular events without targeting the mechanisms involved for diabetes cardiomyopathy and HF. Sodium–glucose cotrans...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Muhammad Shahzeb, Butler, Javed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2019
Materias:
Co-Morbidities
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848945/
https://www.ncbi.nlm.nih.gov/pubmed/31768274
http://dx.doi.org/10.15420/cfr.2019.06.R1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848945/
https://www.ncbi.nlm.nih.gov/pubmed/31768274
http://dx.doi.org/10.15420/cfr.2019.06.R1

Ejemplares similares